SEC Info - Opko Health, Inc. - ‘10-K/A’ for 12/31/09

Opko Health, Inc. – ‘10-K/A’ for 12/31/09 – EX-10.26

On: Thursday, 2/3/11, at 2:31pm ET · For: 12/31/09 · Accession #: 950123-11-8666 · File #: 1-33528

As Of Filer Filing For·On·As Docs:Size Issuer Agent 2/03/11 Opko Health, Inc. 10-K/A 12/31/09 7:1.0M RR Donnelley/FA

Document/Exhibit Description Pages Size 1: 10-K/A Amendment to Annual Report HTML 56K 2: EX-10.25 Material Contract HTML 540K 3: EX-10.26 Material Contract HTML 12K 4: EX-31.1 Certification per Sarbanes-Oxley Act (Section 302) HTML 8K 5: EX-31.2 Certification per Sarbanes-Oxley Act (Section 302) HTML 7K 6: EX-32.1 Certification per Sarbanes-Oxley Act (Section 906) HTML 8K 7: EX-32.2 Certification per Sarbanes-Oxley Act (Section 906) HTML 8K

Exhibit 10.26


2000 GALLOPING HILL ROAD				KENILWORTH, N.J. 07033

TELEPHONE: (908) 298-4000

June 29, 2010

Steven D. Rubin
Executive Vice President
OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, Florida 33137


		RE: The October 12, 2009 Asset Purchase Agreement between Schering Corporation (“Schering”) and OPKO Health, Inc. (“OPKO”) (the “Agreement”)

Dear Mr. Rubin:

This letter confirms our understanding with respect to the schedule for the payment of the Twenty-Five Million Dollars ($25,000,000) that may become due and payable under Paragraph 2.7.2(b) of the Agreement. The schedule for payments made under Section 2.7.2(b) of the Agreement shall be as follows:

(i) Five Million Dollars ($5,000,000) upon NDA approval for an NK-1 Compound, and

(ii) Five Million Dollars ($5,000,000) each year thereafter for the next four (4) years on the anniversary date of such NDA approval.

Please acknowledge your understanding of the payment schedule for Paragraph 2.7.2(b) by having this letter, and the enclosed duplicate copy, signed on behalf of OPKO where indicated and return one fully signed version to your legal contact for Schering.


	Very truly yours.

		Bruce N. Kuhlik Executive Vice President and General Counsel

ACKNOWLEDGED:

OPKO HEALTH, INC.


By:	/s/ *Steven D. Rubin*	Approved for Signature OPKO Legal Dept.

Title:	EVP	By:	/s/ *Kate Inman*
Date:	7-7-2010	Date:	7/7/2010

This ‘10-K/A’ Filing

Date

Other Filings

Filed on:

2/3/11

6/29/10

For Period End:

12/31/09

10-K, 10-K/A, 4, NT 10-K

10/12/09

8-K

List all Filings

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/18/21 Opko Health, Inc. 10-K 12/31/20 111:16M

Opko Health, Inc. – ‘10-K/A’ for 12/31/09 – EX-10.26

On: Thursday, 2/3/11, at 2:31pm ET · For: 12/31/09 · Accession #: 950123-11-8666 · File #: 1-33528

Previous ‘10-K’: ‘10-K/A’ on 11/10/10 for 12/31/09 · Next: ‘10-K’ on 3/16/11 for 12/31/10 · Latest: ‘10-K’ on 3/1/24 for 12/31/23 · 1 Reference: By: Opko Health, Inc. – ‘10-K’ on 2/18/21 for 12/31/20

Amendment to Annual Report — Form 10-K
Filing Table of Contents

EX-10.26 — Material Contract

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

1 Subsequent Filing that References this Filing

Opko Health, Inc. – ‘10-K/A’ for 12/31/09 – EX-10.26

On: Thursday, 2/3/11, at 2:31pm ET · For: 12/31/09 · Accession #: 950123-11-8666 · File #: 1-33528

Previous ‘10-K’: ‘10-K/A’ on 11/10/10 for 12/31/09 · Next: ‘10-K’ on 3/16/11 for 12/31/10 · Latest: ‘10-K’ on 3/1/24 for 12/31/23 · 1 Reference: By: Opko Health, Inc. – ‘10-K’ on 2/18/21 for 12/31/20

Amendment to Annual Report — Form 10-KFiling Table of Contents

EX-10.26 — Material Contract

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

1 Subsequent Filing that References this Filing

Amendment to Annual Report — Form 10-K
Filing Table of Contents